Skip to content

Clinical trials

Phase 2 Acquired Immunodeficiency Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 2 Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20091
20141
20151
20171
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tibotec Pharmaceuticals, Ireland2
Aarhus University Hospital1
Gilead Sciences1
GlaxoSmithKline1
Imperial College London1
Janssen-Cilag International NV1
National Institute of Allergy and Infectious Diseases (NIAID)1
Sheffield Teaching Hospitals NHS Foundation Trust1
ViiV Healthcare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome10
HIV Infections3
Infections2
AIDS-Related Opportunistic Infections1
Cytomegalovirus Infections1
Cytomegalovirus Retinitis1
Hepatitis B1
Pneumonia, Pneumocystis1
Retinitis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.